3rd Quarter - Report

FORBES-TATE for SANOFI U.S.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to Orphan Drug Tax Credit; Issues related to the excise tax for the Vaccine Injury Compensation Fund.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JEFFREY FORBES —
ELIZABETH GREER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act (PL 78-410); Drug pricing issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to flu and RSV vaccines.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JEFFREY FORBES —
ELIZABETH GREER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Issues related to prescription drug pricing, including the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Section 340B of the Public Health Service Act (PL 78-410); Issues related to pharmacy benefit managers.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
JEFFREY FORBES —
ELIZABETH GREER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.